RFX6 anticorps

N° du produit ABIN7246697

Détail du produit anti-RFX6 anticorps

Antigène: RFX6 (Regulatory Factor X 6 (RFX6))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RFX6 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Fusion protein of human RFX6

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:300, ELISA 1:5000-1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.96 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur RFX6

Antigène: RFX6 (Regulatory Factor X 6 (RFX6))

Autre désignation: RFX6 (RFX6 Produits)

Synonymes: anticorps MTFS, anticorps RFXDC1, anticorps dJ955L16.1, anticorps 4930572O07Rik, anticorps Rfxdc1, anticorps regulatory factor X6, anticorps regulatory factor X, 6, anticorps RFX6, anticorps Rfx6

Sujet: The nuclear protein encoded by this gene is a member of the regulatory factor X (RFX) family of transcription factors. Studies in mice suggest that this gene is specifically required for the differentiation of islet cells for the production of insulin, but not for the differentiation of pancreatic polypeptide-producing cells. It regulates the transcription factors involved in beta-cell maturation and function, thus, restricting the expression of the beta-cell differentiation and specification genes. Mutations in this gene are associated with Mitchell-Riley syndrome, which is characterized by neonatal diabetes with pancreatic hypoplasia, duodenal and jejunal atresia, and gall bladder agenesis.

UniProt: Q8HWS3

Pathways: Carbohydrate Homeostasis